Fiche du document
29 avril 2020
- doi: 10.53738/REVMED.2020.16.691.0863
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2020.16.691.0863
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/32348055
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_75CC0CE5FAF44
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
PatientesCiter ce document
M. Krähenbühl et al., « COVID-19 : Prise en charge aux soins intensifs [COVID-19 : Intensive care management] », Serveur académique Lausannois, ID : 10.53738/REVMED.2020.16.691.0863
Métriques
Partage / Export
Résumé
The SARS-coronavirus 2 disease initially reported in December 2019 in China (COVID-19) represents a major challenge for intensive care medicine, due to the high number of ICU admission and the prolonged stay for many patients. Up to 5 % of COVID-19 infected patients develop severe acute hypoxemic respiratory failure requiring invasive mechanical ventilation as supportive treatment. Apart from early antiviral and anti-inflammatory treatment, the management of COVID-19 patients is mainly applying protective mechanical ventilation, to support the injured lungs. However recently acquired data and clinical experience suggest that COVID-19-related ARDS presents some specificities that will be summarized in the present article.